Moleculin Biotech, Inc. (MBRX) has filed a Current Report on Form 8-K dated October 5, 2026, disclosing that the company has posted an investor presentation on its website. The filing indicates that this presentation is intended for use during corporate communications and is being furnished as Exhibit 99.1 to the 8-K.
The company, incorporated in Delaware and headquartered at 5300 Memorial Drive, Suite 950, Houston, TX 77007, is identified as an emerging growth company. The filing confirms that the information contained in the presentation is being furnished and shall not be considered "filed" for the purposes of the Securities Exchange Act of 1934, nor incorporated by reference into other filings unless specifically identified as such.
Additionally, the filing includes a cover page interactive data file formatted as an Inline XBRL document.
